A 2025 University of Virginia study concluded that while GLP-1 drugs significantly reduce body weight and adiposity, they do so "with no clear evidence of cardiorespiratory fitness enhancement"a critical finding given that cardiorespiratory fitness is among the most potent predictors of all-cause and cardiovascular mortality [48]
In conclusion, in this large population-based US cohort of adults with diabetes and on metformin, GLP-1RA use was associated with significantly lower risks for AF, compared either with DPP4i or with non-insulin glucose-lowering agents other than SGLT2i
Compounded medications are not subject to the same high standards as FDA-approved prescription medications and over-the-counter (OTC) drugs
Contact your prescribing healthcare professional immediately, as they may recommend temporary dose reduction, additional anti-nausea medication, or alternative management strategies to help you through the adjustment period
Understanding GLP-1 Drugs and Weight Loss GLP-1 (glucagon-like peptide-1) analogs work by mimicking the bodys natural hormone that regulates appetite, insulin response, and glucose metabolism